全文获取类型
| 收费全文 | 66184篇 |
| 免费 | 4874篇 |
| 国内免费 | 276篇 |
专业分类
| 耳鼻咽喉 | 815篇 |
| 儿科学 | 1848篇 |
| 妇产科学 | 1233篇 |
| 基础医学 | 8528篇 |
| 口腔科学 | 1063篇 |
| 临床医学 | 7129篇 |
| 内科学 | 14990篇 |
| 皮肤病学 | 1154篇 |
| 神经病学 | 6605篇 |
| 特种医学 | 2411篇 |
| 外国民族医学 | 2篇 |
| 外科学 | 10606篇 |
| 综合类 | 458篇 |
| 一般理论 | 47篇 |
| 预防医学 | 4780篇 |
| 眼科学 | 857篇 |
| 药学 | 3821篇 |
| 中国医学 | 110篇 |
| 肿瘤学 | 4877篇 |
出版年
| 2023年 | 314篇 |
| 2022年 | 617篇 |
| 2021年 | 1417篇 |
| 2020年 | 986篇 |
| 2019年 | 1694篇 |
| 2018年 | 1980篇 |
| 2017年 | 1500篇 |
| 2016年 | 1516篇 |
| 2015年 | 1853篇 |
| 2014年 | 2514篇 |
| 2013年 | 3439篇 |
| 2012年 | 4582篇 |
| 2011年 | 4968篇 |
| 2010年 | 2972篇 |
| 2009年 | 2781篇 |
| 2008年 | 4299篇 |
| 2007年 | 4517篇 |
| 2006年 | 4286篇 |
| 2005年 | 4259篇 |
| 2004年 | 3947篇 |
| 2003年 | 3835篇 |
| 2002年 | 3698篇 |
| 2001年 | 571篇 |
| 2000年 | 420篇 |
| 1999年 | 545篇 |
| 1998年 | 770篇 |
| 1997年 | 657篇 |
| 1996年 | 502篇 |
| 1995年 | 540篇 |
| 1994年 | 437篇 |
| 1993年 | 418篇 |
| 1992年 | 269篇 |
| 1991年 | 298篇 |
| 1990年 | 247篇 |
| 1989年 | 211篇 |
| 1988年 | 208篇 |
| 1987年 | 210篇 |
| 1986年 | 201篇 |
| 1985年 | 201篇 |
| 1984年 | 239篇 |
| 1983年 | 204篇 |
| 1982年 | 257篇 |
| 1981年 | 250篇 |
| 1980年 | 218篇 |
| 1979年 | 132篇 |
| 1978年 | 138篇 |
| 1977年 | 118篇 |
| 1976年 | 94篇 |
| 1975年 | 88篇 |
| 1972年 | 83篇 |
排序方式： 共有10000条查询结果，搜索用时 15 毫秒
1.
2.
Henry Havel Gregory Finch Pamela Strode Marc Wolfgang Stephen Zale Iulian Bobe Hagop Youssoufian Matthew Peterson Maggie Liu 《The AAPS journal》2016,18(6):1373-1378
Advancing nanomedicines from concept to clinic requires integration of new science with traditional pharmaceutical development. The medical and commercial success of nanomedicines is greatly facilitated when those charged with developing nanomedicines are cognizant of the unique opportunities and technical challenges that these products present. These individuals must also be knowledgeable about the processes of clinical and product development, including regulatory considerations, to maximize the odds for successful product registration. This article outlines these topics with a goal to accelerate the combination of academic innovation with collaborative industrial scientists who understand pharmaceutical development and regulatory approval requirements—only together can they realize the full potential of nanomedicines for patients. 相似文献
3.
PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease 
下载免费PDF全文
下载免费PDF全文 4.
5.
6.
7.
Hanna Lee Mary K. Tan Andrew T. Yan Paul Angaran Paul Dorian Claudia Bucci Jean C. Gregoire Alan D. Bell Martin S. Green Peter L. Gross Allan Skanes Charles R. Kerr L. Brent Mitchell Jafna L. Cox Vidal Essebag Brett Heilbron Krishnan Ramanathan Carl Fournier Shaun G. Goodman 《The Canadian journal of cardiology》2019,35(2):160-168
Background
Physicians treating nonvalvular atrial fibrillation (AF) assess stroke and bleeding risks when deciding on anticoagulation. The agreement between empirical and physician-estimated risks is unclear. Furthermore, the association between patient and physician sex and anticoagulation decision-making is uncertain.Methods
We pooled data from 2 national primary care physician chart audit databases of patients with AF (Facilitating Review and Education to Optimize Stroke Prevention in Atrial Fibrillation and Coordinated National Network to Engage Physicians in the Care and Treatment of Patients with Atrial Fibrillation Chart Audit) with a combined 1035 physicians (133 female, 902 male) and 10,927 patients (4567 female and 6360 male).Results
Male physicians underestimated stroke risk in female patients and overestimated risk in male patients. Female physicians estimated stroke risk well in female patients but underestimated the risk in male patients. Risk of bleeding was underestimated in all. Despite differences in risk assessment by physician and patient sex, > 90% of patients received anticoagulation across all subgroups. There was modest agreement between physician estimated and calculated (ie, CHADS2 score) stroke risk: Kappa scores were 0.41 (0.35-0.47) for female physicians and 0.34 (0.32-0.36) for male physicians.Conclusions
Our study is the first to examine the association between patient and physician sex influences and stroke and bleeding risk estimation in AF. Although there were differences in agreement between physician estimated stroke risk and calculated CHADS2 scores, these differences were small and unlikely to affect clinical practice; further, despite any perceived differences in the accuracy of risk assessment by sex, most patients received anticoagulation. 相似文献8.
9.
10.
Renaud Snanoudj Nassim Kamar Elisabeth Cassuto Sophie Caillard Marie Metzger Pierre Merville Antoine Thierry Isabelle Jollet Philippe Grimbert Dany Anglicheau Marc Hazzan Gabriel Choukroun Bruno Hurault De Ligny Bénedicte Janbon Vincent Vuiblet Anne Devys Yann Le Meur Michel Delahousse Jean-Luc Taupin 《Kidney international》2019,95(6):1471-1485